| Quarter | Score |
|---|---|
| 2022-Q3 | 65.5 |
| 2022-Q4 | 49.2 |
| 2023-Q1 | 49.1 |
| 2023-Q2 | 47.7 |
| 2023-Q3 | 60.7 |
| 2023-Q4 | 51.1 |
| 2024-Q1 | 56.2 |
| 2024-Q2 | 42.8 |
| 2024-Q3 | 87.6 |
| 2024-Q4 | 64.6 |
| 2025-Q1 | 81.1 |
| 2025-Q2 | 78.9 |
| 2025-Q3 | 81.0 |
| 2025-Q4 | 84.0 |
| 2026-Q1 | 84.5 |
| 2026-Q2 | 86.0 |
Strong consensus, but price is extended — wait for pullback to funds' basis
Trading +55.8% above funds' purchase price — elevated pullback risk
3 of 18 tracked funds hold SHC. Avg conviction: 2.5%. Net adding. First tracked at $11.60 (current +55.8% vs tracked).
Sachem Head Capital has 5.7% in this stock
Prices are approximate, based on 13F reported values (position value / shares), not actual cost basis. Data covers 17 tracked value-oriented funds. Holdings are reported quarterly with a ~45-day lag. Stock splits may affect share count comparisons. Returns are not annualized.
| Fund | % of Portfolio | Action |
|---|---|---|
| Sachem Head Capital | 5.7% | Add |
| Greenlight Capital | 1.9% | Add |
| Citadel Advisors | 0.0% | Add |